Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $725000.0.

  • Dna X's Other Non-Current Assets fell 7567.93% to $725000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $725000.0, marking a year-over-year decrease of 7567.93%. This contributed to the annual value of $948000.0 for FY2024, which is 6789.71% down from last year.
  • According to the latest figures from Q3 2025, Dna X's Other Non-Current Assets is $725000.0, which was down 7567.93% from $780000.0 recorded in Q2 2025.
  • In the past 5 years, Dna X's Other Non-Current Assets registered a high of $6.3 million during Q3 2022, and its lowest value of $725000.0 during Q3 2025.
  • Over the past 5 years, Dna X's median Other Non-Current Assets value was $3.0 million (recorded in 2024), while the average stood at $3.0 million.
  • In the last 5 years, Dna X's Other Non-Current Assets surged by 5662.58% in 2022 and then plummeted by 7567.93% in 2025.
  • Over the past 5 years, Dna X's Other Non-Current Assets (Quarter) stood at $2.5 million in 2021, then increased by 17.75% to $3.0 million in 2022, then fell by 0.64% to $3.0 million in 2023, then plummeted by 67.9% to $948000.0 in 2024, then fell by 23.52% to $725000.0 in 2025.
  • Its Other Non-Current Assets stands at $725000.0 for Q3 2025, versus $780000.0 for Q2 2025 and $821000.0 for Q1 2025.